Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Impact of the Use of IMPROVE for Selection of Patients for Carotid Revascularisation: a Randomized Controlled Multicentre Non-inferiority Trial in Symptomatic Patients With 30-99% Carotid Stenosis

NCT07556887 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT07556887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07556887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Impact of the Use of IMPROVE for Selection of Patients for Carotid Revascularisation: a Randomized Controlled Multicentre Non-inferiority Trial in Symptomatic Patients With 30-99% Carotid Stenosis
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
March 31, 2026
Completion date
August 31, 2031
Enrollment
613 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

atheroscleroses, atherosclerosis cerebral infarction, carotid arteriosclerosis, carotid artery stenosis symptomatic, intraplaque hemorrhage, ischemic cerebral infarction, stroke, stroke (cva) or tia, stroke ischemic, tia (transient ischemic attack)